Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · IEX Real-Time Price · USD
1.320
-0.040 (-2.94%)
At close: Jul 26, 2024, 4:00 PM
1.350
+0.030 (2.27%)
After-hours: Jul 26, 2024, 6:17 PM EDT
Seres Therapeutics Market Cap
Seres Therapeutics has a market cap or net worth of $199.91 million as of July 26, 2024. Its market cap has decreased by -66.02% in one year.
Market Cap
199.91M
Enterprise Value
294.48M
1-Year Change
-66.02%
Ranking
Category
Stock Price
$1.32
Market Cap Chart
Since June 26, 2015, Seres Therapeutics's market cap has decreased from $1.88B to $199.91M, a decrease of -89.39%. That is a compound annual growth rate of -21.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 206.00M | 13.81% |
| Dec 29, 2023 | 181.00M | -74.06% |
| Dec 30, 2022 | 697.70M | -8.81% |
| Dec 31, 2021 | 765.10M | -65.78% |
| Dec 31, 2020 | 2.24B | 825.71% |
| Dec 31, 2019 | 241.50M | 30.75% |
| Dec 31, 2018 | 184.70M | -55.06% |
| Dec 29, 2017 | 411.00M | 2.88% |
| Dec 30, 2016 | 399.50M | -70.85% |
| Dec 31, 2015 | 1.37B | -27.26% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Outset Medical | 200.42M |
| G1 Therapeutics | 199.45M |
| Acumen Pharmaceuticals | 198.86M |
| Candel Therapeutics | 198.35M |
| Biomea Fusion | 198.05M |
| Lineage Cell Therapeutics | 196.36M |
| Accuray | 196.01M |
| Outlook Therapeutics | 195.55M |